Comparing Depo Provera vs Ethinyl Estradiol / Norethindrone
| Depo Provera (medroxyprogesterone) | Ethinyl estradiol / norethindrone |
|
|---|
| Depo Provera (medroxyprogesterone) | Ethinyl estradiol / norethindrone |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Birth Control. Depo Provera may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Postmenopausal Symptoms, Birth Control, Abnormal Uterine Bleeding, Acne, Endometriosis, Gonadotropin Inhibition, Menstrual Disorders, Osteoporosis, Polycystic Ovary Syndrome... View more |
Related suggestions |
|||||||||||||||
| More about Depo Provera (medroxyprogesterone) | More about Ethinyl estradiol / norethindrone | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Depo Provera has an average rating of 4.2 out of 10 from a total of 1969 ratings on Drugs.com. 27% of reviewers reported a positive effect, while 55% reported a negative effect. |
Ethinyl estradiol / norethindrone has an average rating of 5.1 out of 10 from a total of 7647 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 44% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Depo Provera side effects |
|
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Depo Provera prices |
|
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other medroxyprogesterone brands include: depo-subQ provera 104, Provera | Alyacen 1/35, Alyacen 7/7/7, Aranelle, Aurovela 1.5/30, Aurovela 1/20, Aurovela 24 Fe, Aurovela Fe 1.5/30, Aurovela Fe 1/20, Balziva, Blisovi 24 Fe, Blisovi Fe 1.5/30, Blisovi Fe 1/20, Briellyn, Chabelina Fe, Charlotte 24 Fe, Cyonanz, Dasetta 1/35, Dasetta 7/7/7, Estrostep Fe, Feirza 1.5/30, Feirza 1/20, Femcon Fe, femhrt, Femlyv, Finzala, Fyavolv, Galbriela, Gemmily, Generess Fe, Gildagia, Gildess 1.5/30, Gildess 1/20, Gildess 24 Fe, Gildess Fe 1.5/30, Gildess Fe 1/20, Hailey 1.5/30, Hailey 24 Fe, Hailey Fe 1.5/30, Hailey Fe 1/20, Jinteli, Junel 1.5/30, Junel 1/20, Junel Fe 1.5/30, Junel Fe 1/20, Junel Fe 24, Kaitlib Fe, Larin 1.5/30, Larin 1/20, Larin 24 Fe, Larin Fe 1.5/30, Larin Fe 1/20, Layolis Fe, Leena, Leribane, Lo Loestrin Fe, Loestrin 21 1/20, Lomedia 24 Fe, Luizza 1.5/30, Luizza 1/20, Melodetta 24 Fe, Merzee, Mibelas 24 Fe, Microgestin 1.5/30, Microgestin 1/20, Microgestin Fe 1.5/30, Microgestin Fe 1/20, Minastrin 24 Fe, Necon 0.5/35, Necon 7/7/7, Nexesta Fe, Norinyl 1+35, Nortrel 0.5/35, Nortrel 1/35, Nortrel 7/7/7, Nylia 1/35, Nylia 7/7/7, Ortho-Novum 7/7/7, Oshih, Philith, Pirmella 1/35, Pirmella 7/7/7, Rhuzdah, Tarina 24 Fe, Tarina Fe 1/20 EQ, Taysofy, Taytulla, Tilia Fe, Tri-Legest Fe, Vyfemla, Wera, Wymzya Fe, Xarah Fe, Xelria Fe, Zenchent, Zenchent Fe View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
401 hours |
14 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 257 drugs are known to interact with Depo Provera:
|
A total of 500 drugs are known to interact with Ethinyl estradiol / norethindrone:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
|||||||||||||||||
| First Approval Date | |||||||||||||||||
|
September 23, 1960 |
October 15, 1999 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.